Építés alatt – nem éles oldal
Belépés

What researchers published on Krónikus limfoid leukémia (CLL)

9522 papers, newest first.

Showing 60 of 9522

  • Complex karyotype and non-BTK driver mutations associated with BTK inhibitor resistance in chronic lymphocytic leukaemia.British journal of haematology
  • A Phase 1, Dose Escalation Study of Lenalidomide and Ibrutinib for Relapsed/Refractory Chronic Lymphocytic Leukemia.EJHaem
  • Measurable residual disease in chronic lymphocytic leukemia in real-world clinical practice: a single-center experience from 2018-2025.Frontiers in oncology
  • Ibrutinib dose modification and effectiveness in Japanese patients with chronic lymphocytic leukemia: a post-hoc analysis of the Orbit study.Leukemia & lymphoma
  • ÁttekintésChronic Lymphocytic Leukaemia as a Disease of Time: A Four-Clock Framework for Therapeutic Stewardship.European journal of haematology
  • CD20 antigen loss post-venetoclax/anti-CD20 therapy in chronic lymphocytic leukaemia: Frequency, characteristics and potential therapeutic implications.British journal of haematology
  • Atrial Fibrillation During Zanubrutinib Treatment in Chronic Lymphocytic Leukemia With a Historical Ibrutinib Control.EJHaem
  • ÁttekintésA Value-Based Framework for CLL Care: Results of a Scoping Review.Cancers
  • Factors Affecting Time to First Treatment in Early-Stage Chronic Lymphocytic Leukemia: A Single-Center Retrospective Cohort Study.Diagnostics (Basel, Switzerland)
  • Associations of Chronic Lymphocytic Leukemia (CLL) Susceptibility Variants Across the CLL Etiologic Continuum.Cancers
  • Can We use delayed consolidation in chronic lymphocytic leukemia?Leukemia & lymphoma
  • ÁttekintésArtificial Intelligence in Chronic Lymphocytic Leukemia: From Prognostic Biomarkers to Individualized Treatment Selection.Diagnostics (Basel, Switzerland)
  • Late-Onset Invasive Aspergillosis Following Acalabrutinib in 2 Patients With Chronic Lymphocytic Leukemia: A Case Report.Open forum infectious diseases
  • Optimizing Frontline Targeted Therapies in Chronic Lymphocytic Leukemia: An Italian Inter-Regional Delphi Consensus on Patient Risk Stratification, Cardiovascular Safety, and Endpoint Interpretation.European journal of haematology
  • EsetismertetésExtensive Native Aortic Valve Infiltration and Early Bioprosthetic Valve Degeneration in Low-Grade Chronic Lymphocytic Leukemia.JACC. Case reports
  • Fit for the fight: BTK inhibitors prime CAR T cells in CLL.Blood
  • Rapid identification of the high-risk IGLV3-21R110 subgroup of chronic lymphocytic leukemia by flow cytometry.Haematologica
  • Paraneoplastic spongiotic dermatitis associated with progression to treatment-requiring chronic lymphocytic leukemia.Haematologica
  • Intercellular transfer of FOLR2 from nurse-like cells fuels chronic lymphocytic leukemia cell activation and proliferation.Haematologica
  • Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis.Haematologica
  • Efficacy of continuous zanubrutinib monotherapy versus fixed-duration acalabrutinib plus venetoclax or venetoclax plus obinutuzumab in treatment-naïve chronic lymphocytic leukemia: a network meta-analysis.Leukemia & lymphoma
  • How Many Lines of Therapy Do Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receive in Routine Clinical Practice in the United States? Real World Evidence From the Targeted Therapy Era.Clinical lymphoma, myeloma & leukemia
  • Social vulnerability index associates with chronic lymphocytic leukemia survival rates in the Detroit tri-county area.Cancer research communications
  • Borderline tuberculoid leprosy with type 1 reaction mimicking leukaemia cutis in a patient with chronic lymphocytic leukaemia on acalabrutinib.BMJ case reports
  • Optimizing CLL treatment after covalent BTK inhibition.Clinical advances in hematology & oncology : H&O
  • EsetismertetésZanubrutinib Combined With Venetoclax for the Treatment of Central Nervous System-Involved Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Rare Case Report.Cancer reports (Hoboken, N.J.)
  • Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.Blood
  • ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.Cancer medicine
  • Effects of Dioscin on NLRP3 Inflammasome Expression and Apoptosis in Chronic Lymphocytic Leukemia Cells.Immunopharmacology and immunotoxicology
  • Outcomes of Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors (BTKi): A Retrospective Study From a Tertiary Healthcare Center in North India.Cureus
  • Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study.Leukemia research
  • Real-World Treatment Patterns, Tolerability, and Outcomes Among Patients With CLL/SLL Treated With First-Line Ibrutinib, Acalabrutinib, or Zanubrutinib in the US Community Oncology Setting: A Retrospective Cohort Study.EJHaem
  • Decision-Making on First-Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi-Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy.Hematological oncology
  • The evolving evidence ecosystem in chronic lymphocytic leukemia: from linear hierarchies to integrated synthesis.Expert review of hematology
  • A thyroid nodule consistent with chronic lymphocytic leukemia.Endocrinology, diabetes & metabolism case reports
  • Aptamers in cancer research: Focus on leukemia.Chinese medical journal
  • Beyond age: The prognostic impact of frailty on in-hospital outcomes in chronic lymphocytic leukemia.Journal of geriatric oncology
  • Exanthematous drug eruption with reactive T-cell atypia in a patient with accelerated chronic lymphocytic leukemia.International journal of women's dermatology
  • Quantitative systems pharmacology modeling identifies synthetic lethality opportunities with DNA damage response inhibitors in ATM-deficient chronic lymphocytic leukemia - a computational simulation study.Journal of pharmacokinetics and pharmacodynamics
  • ÁttekintésChronic lymphocytic leukemia: recent advances and emerging therapeutic strategies.Blood research
  • Personalized Prediction of Venetoclax-Associated Tumor Lysis Syndrome in Acute Myeloid Leukemia Using Drug Exposure, Genetic Polymorphisms, and Clinical-Laboratory Characteristics.Drug design, development and therapy
  • Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real-World Study.Cancer medicine
  • Comment on "Costs and consequences of cardiovascular toxicity due to Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia".Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
  • EsetismertetésConcurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report.Blood transfusion = Trasfusione del sangue
  • EsetismertetésLeukemia Cutis at the Diagnosis of Chronic Lymphocytic Leukemia: A Case Report.Cureus
  • Scalable Arrayed T-cell CRISPR Screening in Autologous Tumor Co-cultures to Prioritize Combination Partners for T-cell Engagers.Current protocols
  • Real-World Treatment Patterns and Outcomes of Zanubrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at University of California Academic Health Centers: A Retrospective Cohort Study.Oncology and therapy
  • Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.Leukemia
  • T cell-driven venetoclax resistance in chronic lymphocytic leukemia: in vivo preclinical activity of opaganib.Frontiers in immunology
  • EsetismertetésCD23-negative atypical chronic lymphocytic leukemia with a novel three-way translocation t(4;10;13), unmutated: immunoglobulin heavy chain variable gene, and stereotyped subset #6 (case report).The Pan African medical journal
  • TAILORing ibrutinib dose and plasma levels in the real-life patient with chronic lymphocytic leukemia.The Journal of pharmacology and experimental therapeutics
  • Correlation of Epstein-Barr virus (EBV) expressed miRNAs (BART4, BART7, and BHRF1) with chronic lymphocytic leukemia stages.Infectious agents and cancer
  • ÁttekintésNavigating Measurable Residual Disease as a Surrogate Endpoint in Chronic Lymphocytic Leukemia.Hematological oncology
  • ÁttekintésRichter Transformation of Chronic Lymphocytic Leukaemia: Biology, Diagnosis, and an Evolving Therapeutic Landscape.Biomedicines
  • Real-world effectiveness and safety of fixed-duration frontline venetoclax-obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study.Leukemia research
  • Association of Cbl-Interacting Protein CIN85 with Protein Phosphatase 2A (PP2A) Partly Confer Neoplastic Properties to Human Leukemia Cell Lines.Cells
  • Expression of TCTP/HRF and MCL-1 in chronic lymphocytic leukemia: implications for disease pathogenesis.Molecular biology reports
  • The genomic and transcriptomic landscape of chronic lymphocytic leukaemia: Insights from an integrated analysis of 275 patients.British journal of haematology
  • PTPN2/PTPN1 inhibition enhances ex vivo T- cell responses and potentiates mosunetuzumab activity in chronic lymphocytic leukemia.Frontiers in immunology
  • EsetismertetésCollision of Malignant Melanoma and Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Case Report and Literature Review.Dermatopathology (Basel, Switzerland)